Loading clinical trials...

Electronic Real-Time Heart Team Decision-making vs. Usual Care in Patients With Triple-Vessel Coronary Artery Disease and Diabetes Mellitus | Clinical Trials | Clareo Health

NOT_YET_RECRUITINGNA

Electronic Real-Time Heart Team Decision-making vs. Usual Care in Patients With Triple-Vessel Coronary Artery Disease and Diabetes Mellitus

NCT07326514•China National Center for Cardiovascular Diseases

View on ClinicalTrials.gov

Summary

This is a multi-center randomized controlled trial involving patients with 3-vessel coronary artery disease and diabetes mellitus. Enrolled patients will be dividing into real-time heart team decision-making group (intervention group) and usual care group (control group). The intervention group will conduct a real-time online multidisciplinary heart team discussion and decision-making during coronary angiography. The control group will conduct an usual care decision-making.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Age ≥ 18 years;
•2. Diabetes mellitus;
•3. Three-vessel coronary artery disease (≥70% stenosis in the left anterior descending artery, circumflex artery, and right coronary artery system);
•4. Patients who required heart team discussion judging by the interventional cardiologist.

Exclusion Criteria

•1. Prior PCI or CABG;
•2. Acute myocardial infarction with ECG and biomarker tests indicating acute phase;
•3. Concurrent severe valvular heart disease, large vessel disease, or giant ventricular aneurysm requiring surgical intervention;
•4. Concurrent atrial fibrillation or severe arrhythmia;
•5. Other emergency admissions where elective revascularization is contraindicated;
•6. Refusal or rejection of a specific treatment options (PCI or CABG);
•7. Refusal to participate in the study.

Key Dates

Start Date

January 1, 2026

Primary Completion Date

June 1, 2028

Completion Date

June 1, 2028

Last Updated

January 8, 2026

Enrollment

1,350

ESTIMATED participants

Conditions

DiabetesCoronary Artery Disease

Interventions

Real-Time Heart Team Decision-making

OTHER

Contacts

Zhe Zheng, MD, PhD

CONTACT

+86-88396051 zhengzhe@fuwai.com

Feasibility of a Tailored Online Self-compassion Intervention

NCT07051005

Type 1 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)

View study

RECRUITING

Genetic Studies of Insulin and Diabetes

NCT00001987

Diabetes MellitusSevere Insulin Resistance

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 8, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Electronic Real-Time Heart Team Decision-making vs. Usual Care in Patients With Triple-Vessel Coronary Artery Disease and Diabetes Mellitus

Inclusion Criteria

Exclusion Criteria

Feasibility of a Tailored Online Self-compassion Intervention

Genetic Studies of Insulin and Diabetes

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction

Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes